Joining the CEPI-run Centralized Laboratory Network starts a new chapter in the almost century-long history of the illustrious Uganda Virus Research Insitute.
Contacts identified within 21 days of their exposure to Ebola comprise the test group that was supposed to receive doses of the experimental Sudan Ebolavirus
The World Health Organization (WHO) announced yesterday one of the three candidate vaccines against Sudan ebolavirus (SUDV) arrived in the Republic of Uganda. The Sabin Institute's ChAd3-SUDV vaccine is one of the three candidates. The other two, cAdOx1 biEBOV from Oxford University/Jenner Institute/Serum Institute of India and Merck/IAVI's SV-SUDV, will be added to the trial when the vaccines arrive.
A shipment of Ebola vaccine candidates set to be used in a clinical trial have arrived in Uganda. Health minister Jane Ruth Aceng and the WHO Uganda incident manager attended the ceremony to receive the 1,200 doses, Thursday (Dec. 8).